Chronic Migraine: How to Diagnose and Manage
Keywords:
Chronic Migraine; Diagnose; ManageAbstract
No Abstract
References
1. Poungvarin N, eds. Headache. Bangkok: Roenkaew Kanpim, 1990.
2. Poungvarin N. Problems in assessment of headache paitent. In: Poungvarin
N, eds. Headache. Bangkok: Roenkaew Kanpim, 1990: p245-56.
3. Lipton RB, Silberstein SD. The role of headache-related disability in
migraine management: implications for headache treatment guidelines.
Neurology. 2001;56(6 Suppl 1):S35-42.
4. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF.
Migraine prevalence, disease burden and the need for preventive tgerapy.
Neurology. 2007 Jan 30;68(5):343-9.
5. Tepper SJ, Dahlöf CG, Dowson A, Newman L, Mansbach H, Jones M,
et al. Prevalence and diagnosis of migraine in patients consulting their
physician with a complaint of headache: deata from the Landmark Study.
Headache. 2004 Oct;44(9):856-64.
6. House of Commons. A Report of the All-Party Parliamentary Group on
Primary Headache Disorders (APPGPHD). Headache Disorders-Not
Respected, Not Resourced. London: House of Common, 2010.
7. Welch KM, Goadsby PJ. Chronic daily headache: nosology and Pathophysiology.
Curr Opin Neurol. 2002 Jun;15(3):287-95.
8. Headache Classification Committee, Olesen J, Bousser MG, Diener HC,
Dodick D, First M, et al. New appendix criteria open for a broader concept
of chronic migraine. Cephalalgia. 2006 Jun;26(6):742-6.
9. Goadsby PJ, The pharmacology of headache. Prog Neurobiol. 2000 Dec;
62(5):509-25.
10. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P,
et al. Ergotamine in the acute treatment of migraine: a review and European
consensus. Brain. 2000 Jan;123 (Pt 1):9-18.
11. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M,
et al. The International Classification of Headache Disorders, 2nd edition
(ICHD-II) revision of criteria for 8.2 medication-overuse headache. Cephalalgia.
2005 Jun;25(6):460-5.
12. Headache Clasification Committee of the International Headache Society.
The International Classification of Headache Disorders, 2nd edition. Cephalalgia
2004; 24(Suppl 1): 1-160.
13. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population:
burden, diagnosis, and satisfaction with treatment. Neurology. 2008
Aug 19;71(8):559-66.
14. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute
migraine medications and evolution from episodic to chronic migraine:
a longitudinal population based study. Headache. 2008 Sep;48(8):1157-68.
15. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and
chronic migraine: possible mechanisms of interaction. Neurology. 2007
May 22;68(21):1851-61.
16. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al.
Economic burden of transformed migraine: results from the American
Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009
Apr;49(4):498-508.
17. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache
arise de novo in association with regular use of analgesics? Headache.
2003 Mar;43(3):179-90.
18. Wilkinson SM, Becker WJ,Heine JA. Opiated use to control bowel motility
may induce chronic daily headache in patienbts with migraine. Headache.
2001 Mar;41(3):303-9.
19. Goadsby PJ. Is medication-overuse headache a distinct biological entity?
Nat Clin Pract Neurol. 2006 Aug;2(8):401.
20. Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medica
tion0overuse headache in patients with cluster headache. Neurology. 2006
Jul 11;67(1):109-13.
21. Zeeberg P, Olesen J, Jensen R.Probable medication-overuse headache: the
effect of a 2-month drug-free period. Neurology. 2006 Jun 27;66(12):1894-8.
22. Lipton RB, Diamond M, Freitag F, et al. Migraine prevention patterns
in a community sample: results from the American migraine prevalence
and prevention (AMPP) study. Headache 2005; 45: 792-3.
23. Silberstein s, Diamond S, Loder E, et al. Prevalence of migraine sufferers
who are cardidates for preventive therapy: results from the American
migraine study (AMPP) study. Headache 2005; 45: 770-1.
2. Poungvarin N. Problems in assessment of headache paitent. In: Poungvarin
N, eds. Headache. Bangkok: Roenkaew Kanpim, 1990: p245-56.
3. Lipton RB, Silberstein SD. The role of headache-related disability in
migraine management: implications for headache treatment guidelines.
Neurology. 2001;56(6 Suppl 1):S35-42.
4. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF.
Migraine prevalence, disease burden and the need for preventive tgerapy.
Neurology. 2007 Jan 30;68(5):343-9.
5. Tepper SJ, Dahlöf CG, Dowson A, Newman L, Mansbach H, Jones M,
et al. Prevalence and diagnosis of migraine in patients consulting their
physician with a complaint of headache: deata from the Landmark Study.
Headache. 2004 Oct;44(9):856-64.
6. House of Commons. A Report of the All-Party Parliamentary Group on
Primary Headache Disorders (APPGPHD). Headache Disorders-Not
Respected, Not Resourced. London: House of Common, 2010.
7. Welch KM, Goadsby PJ. Chronic daily headache: nosology and Pathophysiology.
Curr Opin Neurol. 2002 Jun;15(3):287-95.
8. Headache Classification Committee, Olesen J, Bousser MG, Diener HC,
Dodick D, First M, et al. New appendix criteria open for a broader concept
of chronic migraine. Cephalalgia. 2006 Jun;26(6):742-6.
9. Goadsby PJ, The pharmacology of headache. Prog Neurobiol. 2000 Dec;
62(5):509-25.
10. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P,
et al. Ergotamine in the acute treatment of migraine: a review and European
consensus. Brain. 2000 Jan;123 (Pt 1):9-18.
11. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M,
et al. The International Classification of Headache Disorders, 2nd edition
(ICHD-II) revision of criteria for 8.2 medication-overuse headache. Cephalalgia.
2005 Jun;25(6):460-5.
12. Headache Clasification Committee of the International Headache Society.
The International Classification of Headache Disorders, 2nd edition. Cephalalgia
2004; 24(Suppl 1): 1-160.
13. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population:
burden, diagnosis, and satisfaction with treatment. Neurology. 2008
Aug 19;71(8):559-66.
14. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute
migraine medications and evolution from episodic to chronic migraine:
a longitudinal population based study. Headache. 2008 Sep;48(8):1157-68.
15. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and
chronic migraine: possible mechanisms of interaction. Neurology. 2007
May 22;68(21):1851-61.
16. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al.
Economic burden of transformed migraine: results from the American
Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009
Apr;49(4):498-508.
17. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache
arise de novo in association with regular use of analgesics? Headache.
2003 Mar;43(3):179-90.
18. Wilkinson SM, Becker WJ,Heine JA. Opiated use to control bowel motility
may induce chronic daily headache in patienbts with migraine. Headache.
2001 Mar;41(3):303-9.
19. Goadsby PJ. Is medication-overuse headache a distinct biological entity?
Nat Clin Pract Neurol. 2006 Aug;2(8):401.
20. Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medica
tion0overuse headache in patients with cluster headache. Neurology. 2006
Jul 11;67(1):109-13.
21. Zeeberg P, Olesen J, Jensen R.Probable medication-overuse headache: the
effect of a 2-month drug-free period. Neurology. 2006 Jun 27;66(12):1894-8.
22. Lipton RB, Diamond M, Freitag F, et al. Migraine prevention patterns
in a community sample: results from the American migraine prevalence
and prevention (AMPP) study. Headache 2005; 45: 792-3.
23. Silberstein s, Diamond S, Loder E, et al. Prevalence of migraine sufferers
who are cardidates for preventive therapy: results from the American
migraine study (AMPP) study. Headache 2005; 45: 770-1.
Downloads
Published
03-04-2020
How to Cite
Poungvarin, N. . (2020). Chronic Migraine: How to Diagnose and Manage. Siriraj Medical Journal, 63(5), 168–170. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241001
Issue
Section
Special Issue
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
